由前沿细胞设计技术塑造的医疗未来
细胞设计医学研究所（RICeD）旨在成为国际化的研发中心，通过创新的细胞设计技术——山口大学的核心优势，不断培育出下一代细胞和基因疗法的创新成果。
RICeD还致力于推动基于创新技术的前沿免疫疗法和基因组医学的实际应用，开发用于癌症和遗传病等疑难疾病的治疗方法，并在伴侣动物中应用和验证这些创新疗法。
通过在人类和伴侣动物之间建立知识互通的积极循环，RICeD将努力通过技术的社会应用形成药物发现生态系统，推动地方社区发展，通过产业创造培养人才，并延长人类和伴侣动物的健康寿命。
![Development Project of an “Index Finger Movement Quantitative Evaluation System” to Visualize Therapeutic Effects on Neurological Disorders Selected for FY2026 Yamaguchi Industry Innovation Acceleration Subsidy [Advance]— Industry-Academia-Government Collaborative Medical Device Development by Professor Takeshita (Department of Neuromuscular Therapeutics / Research Institute for Cell Design Medical Science), Ube Information Systems Co., Ltd., and University-Launched Startup ADDVEMO Inc. —](/~celldesign/wp-content/uploads/2025/12/100_%E6%97%A5%E7%AB%8B%E8%A3%BD%E4%BD%9C%E6%89%80%E3%81%A8%E3%81%AE%E5%85%B1%E5%90%8C%E7%A0%94%E7%A9%B6-1.png)
![[Review] Elucidating the Mechanism of Inflammatory Amplification in Kawasaki Disease: The Role of the IL-33/ST2 Signaling Pathway](/~celldesign/wp-content/uploads/2026/05/129_%E5%B7%9D%E5%B4%8E%E7%97%85.png)
